Chesterfield, MO, United States of America

Michael F McGrath

This inventor holds 6 USPTO granted patents. Top assignee: Monsanto Company. Active years: 1988-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1988-1993

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Michael F McGrath: Innovator in Mammary Parenchyma Growth Enhancement

Introduction

Michael F McGrath is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of mammary parenchyma growth enhancement, holding a total of 6 patents. His innovative methods have the potential to improve dairy production and animal health.

Latest Patents

Among his latest patents is a method for enhancing the growth of mammary parenchyma using a prostaglandin. This method involves administering a substance with a mitogenic effect on mammary epithelial cells through intramammary infusion. Remarkably, good growth enhancement can be achieved using very small quantities of such substances in relatively short periods of time. Another patent focuses on a similar method for enhancing the growth of mammary parenchyma, emphasizing the effectiveness of minimal substance quantities for significant results.

Career Highlights

Michael F McGrath is associated with Monsanto Company, where he has been able to apply his expertise in innovative agricultural solutions. His work has contributed to advancements in animal health and productivity, showcasing his commitment to improving agricultural practices.

Collaborations

Some of his notable coworkers include Robert J Collier and Brent R Larsen, who have collaborated with him on various projects within the company.

Conclusion

Michael F McGrath's contributions to the field of mammary parenchyma growth enhancement reflect his dedication to innovation in agriculture. His patents demonstrate the potential for significant advancements in dairy production and animal health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…